Vaccine components and constituents: Responding to consumer concerns

Barbara E. Eldred; Angela J. Dean; Treasure M. McGuire; Allan L. Nash

doi:10.5694/j.1326-5377.2006.tb00178.x

Vaccine components and constituents: Responding to consumer concerns

Barbara E. Eldred, Angela J. Dean, Treasure M. McGuire^*, Allan L. Nash

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

27 Citations (Scopus)

Abstract

• Vaccination remains a vital strategy in the prevention of infectious disease. • Commercial vaccine formulations contain a range of additives or manufacturing residuals, which may contribute to patient concerns about vaccine safety. • Primary health care professionals are well placed to address patient concerns about vaccine safety. We describe the key constituents present in vaccines, discuss issues related to safety and acceptability of these constituents, and provide a table highlighting constituents of commercially available vaccines in Australia.

Original language	English
Pages (from-to)	170-175
Number of pages	6
Journal	Medical Journal of Australia
Volume	184
Issue number	4
DOIs	https://doi.org/10.5694/j.1326-5377.2006.tb00178.x
Publication status	Published - 20 Feb 2006
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.5694/j.1326-5377.2006.tb00178.x

Cite this

@article{435caa1328b34cf299b11e8ce6c0f097,

title = "Vaccine components and constituents: Responding to consumer concerns",

abstract = "• Vaccination remains a vital strategy in the prevention of infectious disease. • Commercial vaccine formulations contain a range of additives or manufacturing residuals, which may contribute to patient concerns about vaccine safety. • Primary health care professionals are well placed to address patient concerns about vaccine safety. We describe the key constituents present in vaccines, discuss issues related to safety and acceptability of these constituents, and provide a table highlighting constituents of commercially available vaccines in Australia.",

author = "Eldred, {Barbara E.} and Dean, {Angela J.} and McGuire, {Treasure M.} and Nash, {Allan L.}",

year = "2006",

month = feb,

day = "20",

doi = "10.5694/j.1326-5377.2006.tb00178.x",

language = "English",

volume = "184",

pages = "170--175",

journal = "Medical Journal of Australia",

issn = "0025-729X",

publisher = "AUSTRALASIAN MED PUBL CO LTD",

number = "4",

}

TY - JOUR

T1 - Vaccine components and constituents: Responding to consumer concerns

AU - Eldred, Barbara E.

AU - Dean, Angela J.

AU - McGuire, Treasure M.

AU - Nash, Allan L.

PY - 2006/2/20

Y1 - 2006/2/20

N2 - • Vaccination remains a vital strategy in the prevention of infectious disease. • Commercial vaccine formulations contain a range of additives or manufacturing residuals, which may contribute to patient concerns about vaccine safety. • Primary health care professionals are well placed to address patient concerns about vaccine safety. We describe the key constituents present in vaccines, discuss issues related to safety and acceptability of these constituents, and provide a table highlighting constituents of commercially available vaccines in Australia.

AB - • Vaccination remains a vital strategy in the prevention of infectious disease. • Commercial vaccine formulations contain a range of additives or manufacturing residuals, which may contribute to patient concerns about vaccine safety. • Primary health care professionals are well placed to address patient concerns about vaccine safety. We describe the key constituents present in vaccines, discuss issues related to safety and acceptability of these constituents, and provide a table highlighting constituents of commercially available vaccines in Australia.

UR - http://www.scopus.com/inward/record.url?scp=33644619106&partnerID=8YFLogxK

U2 - 10.5694/j.1326-5377.2006.tb00178.x

DO - 10.5694/j.1326-5377.2006.tb00178.x

M3 - Article

C2 - 16489901

AN - SCOPUS:33644619106

SN - 0025-729X

VL - 184

SP - 170

EP - 175

JO - Medical Journal of Australia

JF - Medical Journal of Australia

IS - 4

ER -

Vaccine components and constituents: Responding to consumer concerns

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this